NCOA3 and lung adenocarcinoma: We evaluated AIB1 expression in 167/183 (91.3%) of lung adenocarcinomas and 27/30 (90.0%) of normal lung tissues; lost samples, samples with too few tumor cells (< 300 cells per case), and unrepresentative samples were not used in data compilation.